-
-
Available Formats
- Availability
- Priced From ( in USD )
-
Available Formats
-
- Immediate download
- $65.00
- Add to Cart
-
- Printed Edition
- Ships in 1-2 business days
- $65.00
- Add to Cart
Customers Who Bought This Also Bought
-
ASTM F1635-16
Priced From $48.00 -
ASTM F136-13(2021)e1
Priced From $52.00 -
ASTM F2258-05(2015)
Priced From $48.00 -
ASTM E1263-97(2008)
Priced From $58.00
About This Item
Full Description
1.1 This practice describes a procedure to assess the cytotoxic potential of materials for use in the construction of medical materials and devices using human excised donor (HED) tissues and their derived primary cells taken from the orofacial region.
1.2 This practice may be used either directly to evaluate materials or as a reference against which other cytotoxicity methods may be compared.
1.3 This practice is one of a series of reference methods for assessment of cytotoxic potential, employing different techniques.
1.4 Assessment of cytotoxicity is one of several procedures employed in determining the biological response to a material, as recommended in Practice F748.
1.5 This standard does not purport to address all of the safety concerns, if any, associated with its use. It is the responsibility of the user of this standard to establish appropriate safety and health practices and determine the applicability of regulatory limitations prior to use.
Document History
-
ASTM F1027-86(2017)
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices (Withdrawn 2023)- Most Recent
-
ASTM F1027-86(2012)
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices- Historical Version
-
ASTM F1027-86(2007)
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices- Historical Version
-
ASTM F1027-86(2002)
viewing
Standard Practice for Assessment of Tissue and Cell Compatibility of Orofacial Prosthetic Materials and Devices- Historical Version